MCD — Mycodern SA Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.74% | ||
| Return on Equity | -268.65% | ||
| Operating Margin | 3.44% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | 1.78 | 10.18 | 0.71 | 0.86 | 2.12 | n/a | n/a | -23.5% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mycodern SA is a Poland-based company primarily engaged in the food processing. The Company is a producer of functional food and cutting-edge dietary supplements. The company specializes in the production of dietary supplements and functional foods, including the production of vitamin jellies. The company's offer includes products in the form of hard capsules, softgel capsules, functional shots, oil and liquid forms, as well as functional gummies. The Company produces both its own brands and carries out contract orders for other entities. The Company's research and development department allows to develop its own recipes. The Company's products are sold in over 25 countries, including Europe and beyond. The Company has a modern machine park and develops distribution channels.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 22nd, 2011
- Public Since
- December 30th, 2011
- No. of Employees
- 23
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 30,978,026
- Address
- ul. Jaskowa Dolina 132/20, GDANSK, 80-286
- Web
- https://mycodern.com/
- Phone
- +48 323182723
- Auditors
- GLC Audit Sp. z o.o.
Upcoming Events for MCD
Similar to MCD
Agroliga
Warsaw Stock Exchange
Agroton Public
Warsaw Stock Exchange
Astarta Holding
Warsaw Stock Exchange
Biomass Energy Project SA
Warsaw Stock Exchange
Bio Planet SA
Warsaw Stock Exchange
FAQ
As of Today at 22:10 UTC, shares in Mycodern SA are trading at PLN0.83. This share price information is delayed by 15 minutes.
Shares in Mycodern SA last closed at PLN0.83 and the price had moved by -61.57% over the past 365 days. In terms of relative price strength the Mycodern SA share price has underperformed the FTSE Global All Cap Index by -62.54% over the past year.
There is no consensus recommendation for this security.
Find out moreMycodern SA does not currently pay a dividend.
Mycodern SA does not currently pay a dividend.
Mycodern SA does not currently pay a dividend.
To buy shares in Mycodern SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN0.83, shares in Mycodern SA had a market capitalisation of .
Here are the trading details for Mycodern SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: MCD
Based on an overall assessment of its quality, value and momentum Mycodern SA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mycodern SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -27.29%.
As of the last closing price of PLN0.83, shares in Mycodern SA were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mycodern SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN0.83.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Mycodern SA's directors